What Health Assessments May Be Considered Before a Longevity Program?

Why assessment comes first

Assessment establishes whether a program is appropriate, what should be adjusted, and what would count as a reason to stop. Without it, a treatment decision rests on preference rather than clinical information.

It also sets a baseline. If a plan proceeds, having earlier values recorded makes later review meaningful rather than impressionistic.

Medical history

The conversation covers current and past diagnoses, surgery and procedures, hospital admissions, allergies and reactions, infections, family history, and lifestyle factors such as sleep, activity, alcohol and smoking. Your goals are considered alongside this, not separately from it.

Medication review

Every prescription medicine, over-the-counter product and supplement is reviewed. This identifies interactions, duplicated ingredients and anything that may affect a procedure, particularly medicines influencing bleeding, blood pressure or blood sugar.

Never discontinue prescribed treatment on the basis of general information; changes are made with the prescribing doctor.

Basic laboratory testing

Where testing is indicated, a physician may start with a complete blood count and a basic chemistry panel. Recent reliable results from elsewhere may be accepted, which avoids unnecessary repetition.

More testing is not automatically better. Broad panels without a clinical reason can produce incidental findings that cause worry and further investigation without benefit.

Cardiovascular considerations

Blood pressure and heart rate are commonly checked. Depending on age, history and the program discussed, the physician may review a lipid profile or request an ECG or cardiology input. These are selected case by case, not applied to everyone.

Metabolic health markers

Fasting glucose or HbA1c may be reviewed where relevant, alongside weight, waist measurement and body composition. These give context about metabolic health over time rather than a single snapshot, and abnormal values usually lead to standard medical follow-up rather than straight to a wellness program.

Kidney and liver function

Creatinine with estimated filtration rate, and liver enzymes with bilirubin, are frequently relevant when infusions or extracorporeal procedures are being considered, because both organs influence how fluids and substances are handled. Findings here can change what is offered, or defer it.

Inflammation-related markers where appropriate

Markers such as CRP may be checked in specific circumstances. They are non-specific: a raised value indicates something worth examining but does not identify a cause on its own, and it should never be interpreted in isolation or used to justify a treatment by itself.

Treatment-specific screening

Some programs require their own checks. Extracorporeal procedures such as EBOO or DFPP prompt attention to clotting markers, protein levels and vascular access. Hormone-related discussions require appropriate blood testing rather than symptoms alone. Infusion programs prompt review of kidney function, fluid balance and allergy history.

• Screening is matched to the specific program, not applied uniformly.
• A finding may lead to a modified plan, a referral, or advice not to proceed.
• Testing is selected according to the physician's assessment and the planned program.

Follow-up planning

Before anything begins, agree what would be rechecked, when, and who reviews it, along with how results reach you if you are travelling home. Clear follow-up is part of the assessment, not an afterthought.

Assessment reduces uncertainty; it cannot remove all risk or guarantee suitability or outcomes. Individual responses vary, and continued medical consultation remains the basis of any longevity plan.